Citation Impact
Citing Papers
Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
2008 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
2008 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Heparin-Induced Thrombocytopenia (HIT): An Overview of 230 Patients Treated with Orgaran (Org 10172)
1993
Parenteral Anticoagulants
2012 Standout
Risk of Stroke in Patients with Rheumatism: A Nationwide Longitudinal Population-based Study
2014
Fetal Genotype for the Xenobiotic Metabolizing Enzyme NQO1 Influences Intrauterine Growth Among Infants Whose Mothers Smoked During Pregnancy
2010
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
2005 Standout
Fetal inherited thrombophilias influence the severity of preeclampsia, IUGR and placental abruption
2003
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
2006 Standout
Cerebral venous thrombosis: an update
2007 Standout
Is thrombin generation at the time of an acute thromboembolic episode a predictor of recurrence? The LInköping Study on Thrombosis (LIST) – A 7-year follow-up
2012 StandoutNobel
Human Fibrinogen
1988
Lupus anticoagulant testing: improvements in performance in a UK NEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods
2002
Embolic strokes of undetermined source: the case for a new clinical construct
2014 Standout
Rhabdomyolysis and Acute Kidney Injury
2009 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2008 Standout
Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis
2007 Standout
Screening and management of inherited thrombophilias in the setting of adverse pregnancy outcome
2004
Pre-eclampsia
2005 Standout
Treatment of minor severe acquired haemophilia. Is there a rationale for immunoadsorption?
2015
Pre-eclampsia
2010 Standout
Initiation of Platelet Adhesion by Arrest onto Fibrinogen or Translocation on von Willebrand Factor
1996 Standout
Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate.
1989
Melatonin as a natural ally against oxidative stress: a physicochemical examination
2011 Standout
Obstetric Complications in Patients with Hereditary Thrombophilia Identified Using the LCx Microparticle Enzyme Immunoassay
2007
Inherited Thrombophilias and Adverse Pregnancy Outcome: Screening and Management
2005
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
Laboratory diagnosis of the antiphospholipid syndrome
2002
Outcome of Pulmonary Embolectomy
2006
Genetics of Food Intake Self-Regulation in Childhood: Literature Review and Research Opportunities
2013 Standout
Evaluation of oxidative stress markers in neonates with intra-uterine growth retardation
2008
A review of the medical treatment of primary aldosteronism
2001
Association of the protein C promoter CG haplotype and the factor II G20210A mutation is a risk factor for cerebral venous thrombosis
2005
Factor V Leiden mutation and pregnancy-related complications
2010
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Gallic acid: a versatile antioxidant with promising therapeutic and industrial applications
2015 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Hyperkalemia: A Review
2005
Guidelines for the Primary Prevention of Stroke
2014 Standout
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Self-Assembled Organic Monolayers: Model Systems for Studying Adsorption of Proteins at Aurfaces
1991 StandoutScience
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
2016 Standout
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
Lupus Anticoagulant (LA) Testing: Performance of Clinical Laboratories Assessed by a National Survey Using Lyophilized Affinity-purified Immunoglobulin with LA Activity
2003
An Updated Definition of Stroke for the 21st Century
2013 Standout
Anticoagulants and Thrombolytics
1991
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
2006 Standout
Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia
2001 Standout
Works of J.Y. Borg being referenced
Thrombophilia and fetal growth restriction
2004
Antiphospholipid Antibodies in the Acute Phase of Cerebral Ischaemia in Young Adults: A Descriptive Study of 139 Patients
2002
Thrombophilia and immunological disorders in pregnancies as risk factors for small for gestational age infants
2002
Low molecular weight heparins and hypoaldosteronism.
1990
Quantification of Lupus Anticoagulants in Clinical Samples Using Anti- β2GP1 and Anti-Prothrombin Monoclonal Antibodies
2001
Follow-up of Surgically Treated Patients with Massive Pulmonary Embolism - With Reference to 12 Operated Patients
1982
EPIDEMIOLOGY AND ONE-YEAR OUTCOMES IN PATIENTS WITH ACQUIRED HEMOPHILIA A (AH) IN FRANCE: THE SACHA PROSPECTIVE STUDY
2007
Severe heparin and pentosan polysulfate - induced thrombocytopenias : Clinical aspects - in vitro effects of pentosan polysulfate, low molecular weight (LMW) heparins and oligosaccharides
1986
Evaluation of Sensitivity and Specificity of a Standardized Procedure Using Different Reagents for the Detection of Lupus Anticoagulants
1997
Platelet aggregation occurs in congenital afibrinogenaemia despite the absence of fibrinogen or its fragments in plasma and platelets, as demonstrated by immunoenzymology
1985